Price negotiations remain a key hurdle as South Korea's largest financial groups line up for the sale of the mid-sized insurer, with Shinhan seen as the frontrunner.
Strong demand for wealth, retirement and legacy products, paired with changing capital regimes are pushing Asian life insurers toward equities and alternative assets as industry investments surge.
The proposed protected cell company framework could broaden access to captive insurance arrangements and facilitate insurance-linked securities transactions.
Insurers across China, Taiwan and South Korea are bolstering capital buffers and refining investment strategies as low rates and volatility strain traditional earnings models.
